At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:29 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 5,962,737.88 shares of West Pharmaceutical Services common stock as of September 30, 2026, representing 8.5% of shares outstanding. This is a routine passive stake update filed shortly after the company's strong Q3 2026 earnings report.
- FMR LLC reported beneficial ownership of 5,962,737.88 shares of West Pharmaceutical Services common stock as of September 30, 2026
- The stake represents 8.5% of shares outstanding
- Filing is an amendment to Schedule 13G, indicating passive investment intent
- Filed on November 5, 2026, with data as of September 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access